Belgian health authorities yesterday said they have inspected a pharmaceutical factory in Belgium to find out whether expected delays in the deliveries of AstraZeneca and University of Oxford COVID-19 vaccine are due to production issues.
The European Commission had asked the Belgian government to inspect the factory amid a heated public dispute between the 27-nation bloc and the Anglo-Swedish drugmaker.
EU officials are under tremendous political pressures because the bloc’s vaccine rollout has been much slower than that of Israel or the UK.
Photo: Bloomberg
The Novasep factory in the town of Seneffe is part of the European production chain for the Oxford-AstraZeneca vaccine.
AstraZeneca last week said that it planned to cut initial deliveries in the EU to 31 million doses from the 80 million it had planned due to reduced yields from its manufacturing plants in Europe.
The EU on Wednesday said that it would receive even less than that — just one-quarter of the doses that member nations were supposed to get in the first quarter.
The Belgian factory is one of four AstraZeneca sites included in the contract sealed by the European Commission and the company to produce vaccines for the EU market, the bloc said.
“The Novasep teams worked hard to meet its obligations to AstraZeneca with unprecedented speed and commitment,” Novasep said in a statement.
“Manufacturing the COVID-19 vaccine is a pioneering process in terms of scale, complexity and quantity. We have worked closely with AstraZeneca, and conducted regular and coordinated reviews of the production processes to ensure the active drug substance was delivered on time and met the highest standards for quality and stability,” it said.
France Dammel, a spokesperson for the Belgian minister of health, said that experts from the federal medicine agency inspected the Novasep site. They are now to work with Dutch, Italian and Spanish experts before delivering a report in the coming days.
The EU said it expects to deliver the full amount on time and has threatened to put export inspections on all vaccines made in its territory.
European Commissioner for Health and Food Safety Stella Kyriakides said that AstraZeneca should provide vaccines from its UK facilities if it is unable to meet commitments from factories in the EU.
After a third round of talks with AstraZeneca aimed at resolving the dispute on Wednesday evening, Kyriakides regretted the “continued lack of clarity on the delivery schedule,” and urged AstraZeneca to come up with a clear plan for a quick delivery of the doses reserved by the EU for the first quarter.
A spokesman for AstraZeneca said after the meeting that the company has “committed to even closer coordination to jointly chart a path for the delivery of our vaccine over the coming months as we continue our efforts to bring this vaccine to millions of Europeans at no profit during the pandemic.”
The EU, which has 450 million people, has signed deals for six different vaccines, but so far regulators have only authorized the use of two, one made by Pfizer and another by Moderna.
The EU’s drug regulator is to consider the AstraZeneca vaccine today.
The collapse of the Swiss Birch glacier serves as a chilling warning of the escalating dangers faced by communities worldwide living under the shadow of fragile ice, particularly in Asia, experts said. Footage of the collapse on Wednesday showed a huge cloud of ice and rubble hurtling down the mountainside into the hamlet of Blatten. Swiss Development Cooperation disaster risk reduction adviser Ali Neumann said that while the role of climate change in the case of Blatten “still needs to be investigated,” the wider impacts were clear on the cryosphere — the part of the world covered by frozen water. “Climate change and
Poland is set to hold a presidential runoff election today between two candidates offering starkly different visions for the country’s future. The winner would succeed Polish President Andrzej Duda, a conservative who is finishing his second and final term. The outcome would determine whether Poland embraces a nationalist populist trajectory or pivots more fully toward liberal, pro-European policies. An exit poll by Ipsos would be released when polls close today at 9pm local time, with a margin of error of plus or minus 2 percentage points. Final results are expected tomorrow. Whoever wins can be expected to either help or hinder the
DENIAL: Musk said that the ‘New York Times was lying their ass off,’ after it reported he used so much drugs that he developed bladder problems Elon Musk on Saturday denied a report that he used ketamine and other drugs extensively last year on the US presidential campaign trail. The New York Times on Friday reported that the billionaire adviser to US President Donald Trump used so much ketamine, a powerful anesthetic, that he developed bladder problems. The newspaper said the world’s richest person also took ecstasy and mushrooms, and traveled with a pill box last year, adding that it was not known whether Musk also took drugs while heading the so-called US Department of Government Efficiency (DOGE) after Trump took power in January. In a
It turns out that looming collision between our Milky Way and Andromeda galaxies might not happen after all. Astronomers on Monday said that the probability of the two spiral galaxies colliding is less than previously thought, with a 50-50 chance within the next 10 billion years. That is essentially a coin flip, but still better odds than previous estimates and farther out in time. “As it stands, proclamations of the impending demise of our galaxy seem greatly exaggerated,” the Finnish-led team wrote in a study appearing in Nature Astronomy. While good news for the Milky Way galaxy, the latest forecast might be moot
RSS